Screener
Revolution Medicines, Inc. RVMD Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s shares (diluted)?
- Revolution Medicines, Inc. (RVMD) reported shares (diluted) of 198.1M in Q1 2026.
- How has Revolution Medicines, Inc.'s shares (diluted) changed year-over-year?
- Revolution Medicines, Inc.'s shares (diluted) increased by 5.3% year-over-year, from 188.1M to 198.1M.
- What is the long-term trend for Revolution Medicines, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s shares (diluted) has grown at a 27.1% compound annual growth rate (CAGR), from 290.2M to 756.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Revolution Medicines, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude